XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
XCUR Exicure
- 10.0300
- -0.0600-0.59%
Close Feb 14 16:00 ET
- 10.0300
- 0.00000.00%
Post 20:01 ET
30.48MMarket Cap-4.97P/E (TTM)
10.2250High9.4200Low21.67KVolume10.1100Open10.0900Pre Close212.72KTurnover1.36%Turnover RatioLossP/E (Static)3.04MShares36.000052wk High19.74P/B15.97MFloat Cap1.440052wk Low--Dividend TTM1.59MShs Float576.0000Historical High--Div YieldTTM7.98%Amplitude1.4400Historical Low9.8150Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Andy Yoo
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Andy Yoo
- Director, Chief Executive Officer and President
- --
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Seung Ik Baik
- Director, Chief Financial Officer and Secretary
- --
- Jiyoung Hwang
- Director and Chief Strategic Officer
- 16.97K
- Joshua Miller
- Chief Accounting Officer
- --
- Sangwook Song
- Director
- --
- Minwoo Kang
- Director
- --
- Chang Keun Choi
- Director
- --
- Ho Jung John
- Director
- --
- Dongho Lee
- Independent Director
- 7.22K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025